Isotretinoin Drugs Market Report 2026

Isotretinoin Drugs Market Overview

• Isotretinoin Drugs market size has reached to $1.35 billion in 2025 • Expected to grow to $1.7 billion in 2030 at a compound annual growth rate (CAGR) of 4.7% • Growth Driver: Rising Skin Cancer Cases Drive Growth In Isotretinoin Drugs Market • Market Trend: Advancements in Isotretinoin Capsule Formulations for Severe Acne Treatment • North America was the largest region in 2025.

What Is Covered Under Isotretinoin Drugs Market?

Isotretinoin is a potent medication derived from vitamin A primarily used to treat severe acne, often providing significant improvement in skin conditions. They work by reducing oil production and promoting skin renewal, leading to clearer and healthier skin for many individuals. It's usually prescribed when other treatments have failed, under strict medical supervision, and with careful consideration of potential risks and benefits. The main types of isotretinoin drugs include capsules and injections. Isotretinoin capsules are oral medications that reduce the production of natural oils in the skin, prevent clogged pores, and help treat and prevent acne. The drugs are indicated for severe acne, neuroblastoma, cutaneous T-cell lymphoma, harlequin ichthyosis, Xeroderma pigmentosum, fibrodysplasia ossificans progressiva, squamous cell skin cancers, and others distributed through channels such as hospital pharmacies, retail pharmacies, and online pharmacies.

What Is The Isotretinoin Drugs Market Growth Forecast?

The isotretinoin drugs market size is expected to see steady growth in the next few years. It will grow to $1.7 billion in 2030 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to rising incidence of adult acne, increasing access to dermatology care, growing demand for effective long-term acne solutions, expansion of generic drug manufacturing, improved patient monitoring and safety compliance programs. Major trends in the forecast period include continued use of isotretinoin as a gold-standard therapy for severe acne, growing emphasis on risk management and controlled prescription programs, increasing availability of generic isotretinoin formulations, rising awareness of long-term acne management among adolescents and adults, expansion of isotretinoin use in rare dermatological and oncological indications.

Global Isotretinoin Drugs Market Segmentation

1) By Form: Capsules, Injection 2) By Indication Type: Severe Acne, Neuroblastoma, Cutaneous T-Cell Lymphoma, Harlequin Ichthyosis, Xeroderma Pigmentosum, Fibrodysplasia Ossificans Progressiva, Squamous Cell Skin Cancers, Other Indication Types 3) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Capsules: Soft Gel Capsules, Hard Gel Capsules, Liquid-Filled Capsules 2) By Injection: Intravenous Injection, Intramuscular Injection

What Is The Driver Of The Isotretinoin Drugs Market?

Rising cases of skin cancer are expected to propel the growth of the isotretinoin drugs market going forward. Skin cancer is the uncontrolled growth of abnormal skin cells, typically caused by prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds. Rising cases of skin cancer are primarily due to increased exposure to ultraviolet (UV) radiation from the sun and tanning beds, along with factors like ozone layer depletion and lifestyle changes leading to more outdoor activities without adequate sun protection. Isotretinoin drugs are used for preventing and treating certain types of skin cancer due to their ability to reduce the proliferation of abnormal skin cells. For instance, in January 2024, according to the American Cancer Society, a US-based non-profit organization dedicated to eliminating cancer, there will be 108,270 reported cases of skin cancer, reflecting a 3.2% increase from the 104,930 cases reported in 2023. Therefore, rising cases of skin cancer will drive the growth of the isotretinoin drugs industry.

Key Players In The Global Isotretinoin Drugs Market

Major companies operating in the isotretinoin drugs market are F. Hoffmann-La Roche Ltd., Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Hetero Drugs Ltd., Sun Pharmaceuticals Industries Limited, Intas Pharmaceuticals Ltd., Aurobindo Pharma, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Amneal Pharmaceuticals LLC, Lupin Pharmaceuticals Inc, Zydus Lifesciences Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd, Alembic Pharmaceuticals Ltd, Ajanta Pharma Ltd, Strides Pharma Science Limited, Wockhardt Ltd., Douglas Pharmaceuticals Limited, Chongqing Huapont Pharm Co. Ltd., Cipher Pharmaceuticals Inc.

Global Isotretinoin Drugs Market Trends and Insights

Major companies operating in the isotretinoin drugs market are focusing on advancements in formulations, such as isotretinoin capsules, to enhance treatment options and increase accessibility for patients. Isotretinoin capsules are prescribed for severe acne cases like nodular or cystic acne, with strict usage guidelines due to significant side effects, especially the high risk of birth defects. For instance, in July 2023, Upsher-Smith Laboratories, LLC, a US-based pharmaceutical company, launched the first Isotretinoin Capsules USP. They are available in 10 mg, 20 mg, 30 mg, and 40 mg dosages. These capsules are therapeutically equivalent (TE code AB1) to the brand Accutane. This medication is prescribed for the treatment of severe acne, offering a proven solution for difficult cases.

What Are Latest Mergers And Acquisitions In The Isotretinoin Drugs Market?

In January 2024, CHEPLAPHARM Arzneimittel GmbH, a Germany-based pharmaceutical company, acquired Roaccutane from F. Hoffmann-La Roche Ltd. for an undisclosed amount. This acquisition strengthens CHEPLAPHARM Group's dermatological portfolio by securing global rights to Roaccutane and providing this well-established retinoid medicine for treating severe acne and as a therapeutic option worldwide. F. Hoffmann-La Roche Ltd. is a Switzerland-based healthcare company engaged in the manufacturing of isotretinoin drugs such as Roaccutane.

Regional Insights

North America was the largest region in the isotretinoin drugs market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Isotretinoin Drugs Market?

The isotretinoin drugs market consists of sales of softgels, tablets, and ointments. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Isotretinoin Drugs Market Report 2026?

The isotretinoin drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the isotretinoin drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.